Overview

• The investments will generate more than 3,000 direct specialist positions and around 20,000 indirect jobs across key regions including Mexico City, Hidalgo, Veracruz, the State of Mexico and Tlaxcala.
• Boehringer Ingelheim is allocating 3.5 billion pesos to expand its Xochimilco tablet plant into the world’s largest facility with an annual output of 5 billion tablets for domestic and export markets.
• Carnot Laboratorios will invest 3.5 billion pesos to build a biotechnology manufacturing plant in Hidalgo that will create 600 specialized roles and serve over 30 export markets.
• Bayer will dedicate 3 billion pesos over the next five years to modernize active-ingredient production at its Orizaba, Lerma and Tlaxcala plants and to enhance clinical research capacity.
• AstraZeneca will invest more than 2 billion pesos over two years to expand clinical trial infrastructure, digital services and a new manufacturing site in the State of Mexico, adding over 600 specialist jobs.